Le Lézard
Classified in: Health, Science and technology
Subjects: OFR, ACC, TRI

Anglo-Norwegian EXACT Therapeutics Raises NOK 155 Million and Lists on Oslo Stock Exchange's Merkur Market


OSLO, Norway and LONDON, July 14, 2020 /PRNewswire/ -- EXACT THERAPEUTICS AS ("EXACT-Tx" or the "Company") (Oslo: EXTX-ME), a clinical stage precision medicine company evaluating Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today announces that its shares have been admitted to trading on Oslo Stock Exchange's Merkur Market under the ticker EXTX-ME with first day of trading 14 July 2020, following the successful completion of a NOK 155 million private placement.

The offering attracted strong interest from existing shareholders including Canica, Sundt, Andenaess, Investinor and P53/TDVeen who anchored the financing, and Norwegian family offices and institutions including Nordea. The offering was significantly upsized on the back of strong demand. 

The net proceeds from the private placement will be used for:

Comment

"We are delighted with the success of this financing and the interest from investors is a strong recognition of both the broad potential of ACT® as well as the continued progress of the phase I ACTIVATE study evaluating ACT® co-administered with chemotherapy in patients with metastatic colorectal and pancreatic cancer," says Dr Rafiq Hasan, CEO designate of EXACT-Tx.

Chair of the Board and healthcare investor Dr. Masha Strømme further comments: "The Merkur listing facilitated the strengthening of the shareholder base which will help further our mission to extend and enrich patient lives through targeted ACT® therapeutic enhancement."

About EXACT

EXACT-Tx is a clinical stage Anglo-Norwegian biotech company developing a technology platform for targeted therapeutic enhancement ? Acoustic Cluster Therapy (ACT®). ACT® sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement ? with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. www.exact-tx.com

For more information contact:

Dr Masha Strømme, Chair EXACT Therapeutics
[email protected]

Richard Hayhurst/Janet Joy RHApr
Tel.: +44-(0)7711-821527
[email protected]

SOURCE EXACT Therapeutics


These press releases may also interest you

at 19:05
U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's Disease
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
Media Advisory - Minister Saks in Winnipeg to highlight Budget 2024: Fairness for Every Generation investments to boost research funding in Canada
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting A Solution Panel Aims to Find Solutions for the Veteran Suicide Crisis with National Thought Leaders Tulsi Gabbard, Tim Kennedy, and Dan Hollaway
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

at 18:15
Equality Health Foundation Expands Reach to Virginia and Louisiana
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...

at 18:01
Aflac Incorporated Revises Time of First Quarter Webcast Teleconference to 7:00 a.m. (ET) on Thursday, May 2, 2024
Aflac Incorporated announced today that it has revised the time of its first quarter webcast teleconference call on Thursday, May 2, 2024 to 7:00 a.m. (ET), which is one hour earlier than the originally scheduled 8:00 a.m. start time, to avoid...

at 17:48
Hundreds of Community Leaders Kick Off Multi-city Convening in Bakersfield With a Simple Message: Do Not Cut San Joaquin Valley Programs & Services
On Wednesday, April 17, the San Joaquin Valley Health Fund (SJVHF) launched "Equity on the Road" a multi-city series of community town halls to deepen local understanding of state issues and to advocate for more resources in the San Joaquin Valley....

More news about Health...


News published on and distributed by: